Hong Shan to Humans
This is a "connection" page, showing publications Hong Shan has written about Humans.
Connection Strength
0.131
-
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology. 2021 Jun 10; 19(1):173.
Score: 0.008
-
Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment. ACS Appl Mater Interfaces. 2021 May 12; 13(18):20995-21006.
Score: 0.008
-
Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy. Int J Med Sci. 2020; 17(16):2561-2569.
Score: 0.007
-
Upper Gastrointestinal Bleeding Caused by SARS-CoV-2 Infection. Am J Gastroenterol. 2020 09; 115(9):1541-1542.
Score: 0.007
-
Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020 05 18; 12(4):322-325.
Score: 0.007
-
Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020 06; 69(6):997-1001.
Score: 0.007
-
Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020 05; 158(6):1831-1833.e3.
Score: 0.007
-
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020 04; 295(1):202-207.
Score: 0.007
-
Generation of functional hepatocyte-like cells from human bone marrow mesenchymal stem cells by overexpression of transcription factor HNF4a and FOXA2. Hepatobiliary Pancreat Dis Int. 2019 Dec; 18(6):546-556.
Score: 0.007
-
ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling. Theranostics. 2019; 9(15):4391-4408.
Score: 0.007
-
Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials. J Ethnopharmacol. 2019 Jun 12; 237:307-313.
Score: 0.007
-
Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS. Acta Radiol. 2018 Feb; 59(2):140-146.
Score: 0.006
-
miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway. Oncol Rep. 2017 Jul; 38(1):393-401.
Score: 0.006
-
Mycotoxin Contamination of Rice in China. J Food Sci. 2017 Mar; 82(3):573-584.
Score: 0.006
-
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 2021 07 22; 7(1):61.
Score: 0.002
-
A predictive score for progression of COVID-19 in hospitalized persons: a cohort study. NPJ Prim Care Respir Med. 2021 06 03; 31(1):33.
Score: 0.002
-
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
Score: 0.002
-
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation. Nat Commun. 2021 05 11; 12(1):2697.
Score: 0.002
-
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients. Cell Mol Immunol. 2021 03; 18(3):621-631.
Score: 0.002
-
Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020 Jun 29; 21(1):163.
Score: 0.002
-
Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15". Ultraschall Med. 2020 08; 41(4):441-442.
Score: 0.002
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.002
-
Successful use of methylprednisolone for treating severe COVID-19. J Allergy Clin Immunol. 2020 08; 146(2):325-327.
Score: 0.002
-
Artificial intelligence-enabled rapid diagnosis of patients with COVID-19. Nat Med. 2020 08; 26(8):1224-1228.
Score: 0.002
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.002
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.002
-
A Clinical Study of Noninvasive Assessment of Lung Lesions in Patients with Coronavirus Disease-19 (COVID-19) by Bedside Ultrasound. Ultraschall Med. 2020 Jun; 41(3):300-307.
Score: 0.002
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.002
-
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020 05; 5(5):434-435.
Score: 0.002
-
Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 04 30; 382(18):1708-1720.
Score: 0.002
-
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020 06; 295(3):200463.
Score: 0.002
-
Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma. Nanotechnology. 2019 Apr 26; 30(17):175101.
Score: 0.002
-
Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy. Biomater Sci. 2018 Dec 18; 7(1):262-271.
Score: 0.002
-
Reduced arsenic availability and plant uptake and improved soil microbial diversity through combined addition of ferrihydrite and Trichoderma asperellum SM-12F1. Environ Sci Pollut Res Int. 2018 Aug; 25(24):24125-24134.
Score: 0.002
-
MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Cell Biochem Funct. 2017 Mar; 35(2):98-104.
Score: 0.001